Cite
Borel C, Regnier-Gavier O, Carinato H, et al. Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget. 2018;9(101):37581-37588doi: 10.18632/oncotarget.26506.
Borel, C., Regnier-Gavier, O., Carinato, H., Guihard, S., Antoni, D., Demarchi, M., Sirlin, F., Exinger, D., Petit-Jean, E., Thiery, A., Bronner, G., Schultz, P., Flesch, H., Frasie, V., Prébay, D., Petit, T., Jung, A. C., Burgy, M., & Coliat, P. (2018). Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget, 9(101), 37581-37588. https://doi.org/10.18632/oncotarget.26506
Borel, Christian, et al. "Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer." Oncotarget vol. 9,101 (2018): 37581-37588. doi: https://doi.org/10.18632/oncotarget.26506
Borel C, Regnier-Gavier O, Carinato H, Guihard S, Antoni D, Demarchi M, Sirlin F, Exinger D, Petit-Jean E, Thiery A, Bronner G, Schultz P, Flesch H, Frasie V, Prébay D, Petit T, Jung AC, Burgy M, Coliat P. Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget. 2018 Dec 25;9(101):37581-37588. doi: 10.18632/oncotarget.26506. eCollection 2018 Dec 25. PMID: 30680071; PMCID: PMC6331031.
Copy
Download .nbib